1. Preface 
       1.1. Report Scope and Market Segmentation 
       1.2. Research Highlights

2. Assumptions and Research Methodology 
       2.1. Assumptions and Acronyms Used
       2.2. Research Methodology

3. Executive Summary

4. Market Overview
       4.1. Product Overview
       4.2. Market Dynamics
                4.2.1. Drivers and Restraints Snapshot Analysis
                4.2.2. Drivers
                4.2.3. Restraints
                4.2.4. Opportunity
       4.3. Global Critical Limb Ischemia Treatment Market Revenue Projection (US$ Mn), 2017–2027
       4.4. Global Critical Limb Ischemia Treatment Market Outlook

5. Market Outlook
       5.1. Pipeline Analysis
       5.2. Key Industry Events
       5.3. Regulatory Scenario for Device
       5.4. Prevalence of Critical Limb Ischemia Globally/Region
       5.5. Major Research Institutes Involved
       5.6. Technological Advancement

6. Global Critical Limb Ischemia Treatment Market Analysis, by Treatment
       6.1. Key Findings
       6.2. Introduction 
       6.3. Global Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
       6.4. Global Critical Limb Ischemia Treatment Market Forecast, by Treatment 
                6.4.1. Devices
                           6.4.1.1. Embolic Protection Devices
                           6.4.1.2. Peripheral Dilatation Systems
                                        6.4.1.2.1. Balloon Dilators
                                        6.4.1.2.2. Vascular stents
                6.4.2. Medications
                           6.4.2.1. Antiplatelet Drugs
                           6.4.2.2. Antihypertensive Agents
                           6.4.2.3. Lipid-lowering Agents
                           6.4.2.4. Antithrombotic Agents
                           6.4.2.5. Others
       6.5. Global Critical Limb Ischemia Treatment Market Analysis, by Treatment 

7. Global Critical Limb Ischemia Treatment Market Analysis, by Region
       7.1. Global Critical Limb Ischemia Treatment Market Scenario, by Country
       7.2. Global Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Region
       7.3. Global Critical Limb Ischemia Treatment Market Forecast, by Region
                7.3.1. North America
                7.3.2. Europe
                7.3.3. Asia Pacific
                7.3.4. Latin America
                7.3.5. Middle East & Africa

8. North America Critical Limb Ischemia Treatment Market Analysis
       8.1. Key Findings
       8.2. North America Critical Limb Ischemia Treatment Market Overview
       8.3. North America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country
       8.4. North America Critical Limb Ischemia Treatment Market Forecast, by Country
                8.4.1. U.S.
                8.4.2. Canada
       8.5. North America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
       8.6. North America Critical Limb Ischemia Treatment Market Forecast, by Treatment
                8.6.1. Devices
                           8.6.1.1. Embolic Protection Devices
                           8.6.1.2. Peripheral Dilatation Systems
                                        8.6.1.2.1. Balloon Dilators
                                        8.6.1.2.2. Vascular stents
                8.6.2. Medications
                           8.6.2.1. Antiplatelet Drugs
                           8.6.2.2. Antihypertensive Agents
                           8.6.2.3. Lipid-lowering Agents
                           8.6.2.4. Antithrombotic Agents
                           8.6.2.5. Others

9. Europe Critical Limb Ischemia Treatment Market Analysis
       9.1. Key Findings
       9.2. Europe Critical Limb Ischemia Treatment Market Overview
       9.3. Europe Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
       9.4. Europe Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
                9.4.1. Germany
                9.4.2. France
                9.4.3. U.K.
                9.4.4. Italy
                9.4.5. Spain
                9.4.6. Rest of Europe
       9.5. Europe Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
       9.6. Europe Critical Limb Ischemia Treatment Market Forecast, by Treatment
                9.6.1. Devices
                           9.6.1.1. Embolic Protection Devices
                           9.6.1.2. Peripheral Dilatation Systems
                                        9.6.1.2.1. Balloon Dilators
                                        9.6.1.2.2. Vascular stents
                9.6.2. Medications
                           9.6.2.1. Antiplatelet Drugs
                           9.6.2.2. Antihypertensive Agents
                           9.6.2.3. Lipid-lowering Agents
                           9.6.2.4. Antithrombotic Agents
                           9.6.2.5. Others

10. Asia Pacific Critical Limb Ischemia Treatment Market Analysis
       10.1. Key Findings
       10.2. Asia Pacific Critical Limb Ischemia Treatment Market Overview
       10.3. Asia Pacific Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
       10.4. Asia Pacific Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
                10.4.1. Japan
                10.4.2. China
                10.4.3. India
                10.4.4. Australia & New Zealand
                10.4.5. Rest of Asia Pacific
       10.5. Asia Pacific Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
       10.6. Asia Pacific Critical Limb Ischemia Treatment Market Forecast, by Treatment
                10.6.1. Devices
                           10.6.1.1. Embolic Protection Devices
                           10.6.1.2. Peripheral Dilatation Systems
                                        10.6.1.2.1. Balloon Dilators
                                        10.6.1.2.2. Vascular stents
                10.6.2. Medications
                           10.6.2.1. Antiplatelet Drugs
                           10.6.2.2. Antihypertensive Agents
                           10.6.2.3. Lipid-lowering Agents
                           10.6.2.4. Antithrombotic Agents
                           10.6.2.5. Others

11. Latin America Critical Limb Ischemia Treatment Market Analysis
       11.1. Key Findings
       11.2. Latin America Critical Limb Ischemia Treatment Market Overview
       11.3. Latin America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
       11.4. Latin America Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
                11.4.1. Brazil
                11.4.2. Mexico
                11.4.3. Rest of Latin America
       11.5. Latin America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
       11.6. Latin America Critical Limb Ischemia Treatment Market Forecast, by Treatment
                11.6.1. Devices
                           11.6.1.1. Embolic Protection Devices
                           11.6.1.2. Peripheral Dilatation Systems
                                        11.6.1.2.1. Balloon Dilators
                                        11.6.1.2.2. Vascular stents
                11.6.2. Medications
                           11.6.2.1. Antiplatelet Drugs
                           11.6.2.2. Antihypertensive Agents
                           11.6.2.3. Lipid-lowering Agents
                           11.6.2.4. Antithrombotic Agents
                           11.6.2.5. Others

12. Middle East & Africa Critical Limb Ischemia Treatment Market Analysis
       12.1. Key Findings
       12.2. Middle East & Africa Critical Limb Ischemia Treatment Market Overview
       12.3. Middle East & Africa Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
       12.4. Middle East & Africa Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
                12.4.1. GCC Countries
                12.4.2. South Africa
                12.4.3. Rest of Middle East & Africa
       12.5. Middle East & Africa Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
       12.6. Middle East & Africa Critical Limb Ischemia Treatment Market Forecast, by Treatment
                12.6.1. Devices
                           12.6.1.1. Embolic Protection Devices
                           12.6.1.2. Peripheral Dilatation Systems
                                        12.6.1.2.1. Balloon Dilators
                                        12.6.1.2.2. Vascular stents
                12.6.2. Medications
                           12.6.2.1. Antiplatelet Drugs
                           12.6.2.2. Antihypertensive Agents
                           12.6.2.3. Lipid-lowering Agents
                           12.6.2.4. Antithrombotic Agents
                           12.6.2.5. Others

13. Competition Landscape
       13.1. Competition Matrix 
       13.2. Company Profile 
                13.2.1. Medtronic plc
                           13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.1.2. Financial Overview
                           13.2.1.3. Product Portfolio
                           13.2.1.4. SWOT Analysis
                           13.2.1.5. Strategic Overview
                13.2.2. Boston Scientific Corporation
                           13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.2.2. Financial Overview
                           13.2.2.3. Product Portfolio
                           13.2.2.4. SWOT Analysis
                           13.2.2.5. Strategic Overview
                13.2.3. Cesca Therapeutics, Inc.
                           13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.3.2. Financial Overview
                           13.2.3.3. Product Portfolio
                           13.2.3.4. SWOT Analysis
                           13.2.3.5. Strategic Overview
                13.2.4. Abbott Laboratories
                           13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.4.2. Financial Overview
                           13.2.4.3. Product Portfolio
                           13.2.4.4. SWOT Analysis
                           13.2.4.5. Strategic Overview
                13.2.5. Pluristem Therapeutics, Inc.
                           13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.5.2. Financial Overview
                           13.2.5.3. Product Portfolio
                           13.2.5.4. SWOT Analysis
                           13.2.5.5. Strategic Overview
                13.2.6. Rexgenero Ltd.
                           13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.6.2. Financial Overview
                           13.2.6.3. Product Portfolio
                           13.2.6.4. SWOT Analysis
                           13.2.6.5. Strategic Overview
                13.2.7. LimFlow SA
                           13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.7.2. Financial Overview
                           13.2.7.3. Product Portfolio
                           13.2.7.4. SWOT Analysis
                           13.2.7.5. Strategic Overview
                13.2.8. Micro Medical Solutions
                           13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.8.2. Financial Overview
                           13.2.8.3. Product Portfolio
                           13.2.8.4. SWOT Analysis
                           13.2.8.5. Strategic Overview
                13.2.9. Cardiovascular System, Inc.
                           13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                           13.2.9.2. Financial Overview
                           13.2.9.3. Product Portfolio
                           13.2.9.4. SWOT Analysis
                           13.2.9.5. Strategic Overview

List of Tables
Table 01: Pipeline Analysis
Table 02: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 03: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 04: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 05: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 06: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 09: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2017–2027
Table 10: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems, 2017–2027
Table 11: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications, 2017–2027
Table 12: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 14: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2017–2027
Table 15: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems, 2017–2027
Table 16: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications, 2017–2027
Table 17: Asia Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 20: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2017–2027
Table 21: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems, 2017–2027
Table 22: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications, 2017–2027
Table 23: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 25: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2017–2027
Table 26: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems, 2017–2027
Table 27: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications, 2017–2027
Table 28: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 29: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 30: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2017–2027
Table 31: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems, 2017–2027
Table 32: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications, 2017–2027
Table 33: Medtronic plc, Business Overview
Table 34: Boston Scientific Corporation Product Offerings
Table 35: Cesca Therapeutics, Inc., Products & Services Offered
Table 36: Abbott Laboratories, Business Overview
Table 37: Pluristem Therapeutics, Inc., Products & Services Offered
Table 38: Rexgenero Ltd., Products & Services Offered
Table 39: LimFlow SA, Products & Services Offered
Table 40: Micro Medical Solutions, Products & Services Offered
Table 41: Cardiovascular Systems, Inc., Products & Services Offered

 

List of Figures
Figure 01: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global Critical Limb Ischemia Treatment Market Revenue Projection (US$ Mn), 2017–2027
Figure 03: Global Critical Limb Ischemia Treatment Market Value Share, by Treatment, 2018
Figure 04: Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2018
Figure 05: U.S. FDA Medical Devices Approval Criteria
Figure 06: Classification of Medical Devices
Figure 07: European Approval for Medical Devices - Regulatory Pathway (Class IIb Devices only)
Figure 08: Regulatory Approval Process - U.S.
Figure 09: Regulatory Approval Process - Europe 
Figure 10: Regulatory Approval Process - Japan
Figure 11: Prevalence of Critical Limb Ischemia Globally/Region
Figure 12: Global Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 13: Global Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 14: Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Devices, 2017–2027
Figure 15: Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Medications, 2017–2027
Figure 16: Global Critical Limb Ischemia Treatment Market Scenario, by Country
Figure 17: Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2018 and 2027 
Figure 18: Global Critical Limb Ischemia Treatment Market Attractiveness, by Region, 2019–2027
Figure 19: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 20: North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 21: North America Critical Limb Ischemia Treatment Market Attractiveness, by Country, 2019–2027
Figure 22: North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 23: North America Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 24: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 25: Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 26: Europe Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 27: Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 28: Europe Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 29: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 30: Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 31: Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 32: Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 33: Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 34: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 35: Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 36: Latin America Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 37: Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 38: Latin America Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 39: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 40: Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 41: Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 42: Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 43: Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 44: Medtronic plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 45: Medtronic plc, Breakdown of Net Sales (%), by Geography, 2018
Figure 46: Medtronic plc, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 47: Medtronic plc, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 48: Boston Scientific Corporation, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 49: Boston Scientific Corporation, Breakdown of Net Sales, by Region, 2017
Figure 50: Boston Scientific Corporation, Breakdown of Net Sales, by Business Segment, 2017
Figure 51: Cesca Therapeutics Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 52: Cesca Therapeutics Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 53: Cesca Therapeutics Inc. Breakdown of Net Sales, by Region, 2018
Figure 54: Cesca Therapeutics Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 55: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 56: Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2016–2018
Figure 57: Abbott Laboratories, Breakdown of Net Sales, by Countries, 2018
Figure 58: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2018
Figure 59: Cardiovascular Systems, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 60: Cardiovascular Systems, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2016–2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Critical Limb Ischemia Treatment

Buy Now